Unfortunately, there is not yet a ghrelin system based therapy that ensures a sustained weight loss, although ghrelin antagonist and/or GOAT inhibitors may be considerate good therapeutic candidates for the treatment of T2DM and obesity. The gene discussed is GHRL; the disease is obesity due to melanocortin 4 receptor deficiency.